Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001065280 | SCV001230236 | uncertain significance | Renal carnitine transport defect | 2021-08-31 | criteria provided, single submitter | clinical testing | This sequence change replaces leucine with valine at codon 321 of the SLC22A5 protein (p.Leu321Val). The leucine residue is moderately conserved and there is a small physicochemical difference between leucine and valine. This variant is present in population databases (rs761264590, ExAC 0.003%). This variant has not been reported in the literature in individuals affected with SLC22A5-related conditions. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Giacomini Lab, |
RCV001065280 | SCV002576595 | uncertain significance | Renal carnitine transport defect | 2022-10-03 | criteria provided, single submitter | research | |
Natera, |
RCV001065280 | SCV001462816 | uncertain significance | Renal carnitine transport defect | 2020-09-16 | no assertion criteria provided | clinical testing |